A generation gap may be emerging within the gold rush of computer scientists and software developers racing to weaponize AI for the fight against COVID-19.

A company with a name that sounds like a book title has formed to beat back COVID and future health crises by tapping the powers of AI.

If an AI-brained surgical robot refuses to do its job at a critical moment in the OR, who is responsible for stepping in?

One state’s largest health system is combining forces with that state’s top medical school to launch a multidisciplinary digital health center that’s notable for its apparent velocity out of the gate.

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Humana is sinking $100 million into a primary care startup to send doctors into patients’ homes via 1-touch telemed or old-school housecalls.

Before COVID hit, the U.S. was importing around a third of its PPE from China. Then that most populous of all countries moved to protect its own people, keeping what it used to ship.

Researchers have demonstrated the use of an AI tool that can accurately identify or rule out prostate cancer on digitized pathology slides from core needle biopsies.

The FDA has OK’d the sixth medical AI application developed by Israel-based Zebra Medical Vision. The latest iteration helps breast-specialized radiologists by flagging questionable lesions appearing in 2D mammograms.

Medical journals accepting reprint fees are much more likely to publish articles written by authors who received industry payments.